Skip to main content
. 2015 Mar 17;83(4):1458–1464. doi: 10.1128/IAI.02790-14

TABLE 1.

Bacterial strains and plasmid used in this study

Bacterial strain or plasmid Characteristicsa Source or referenceb
B. abortus strains
    B. abortus S2308 Wild type, smooth LIDI
    B. abortus S2308(pBBR4-gfp) Wild type expressing GFP, smooth LIDI
    B. abortus S19 Vaccine strain, smooth LIDI
    B. abortus RB51 Vaccine strain, rough LIDI
    B. abortus Δmfp::kan Kanr, mutant of S2308, smooth CICVyA-INTA
    B. abortus Δmfp(pBBR4-gfp) Kanr Ampr, mutant of S2308, smooth This study
    B. abortus Δmfp(pBBR1-mfp) Kanr Cmr, mutant of S2308, smooth CICVyA-INTA
    B. abortus Δmfp(pBBR1-mfp, pBBR4-gfp) Kanr Cmr Ampr, mutant of S2308, smooth This study
    B. abortus Δomp19::kan Kanr, mutant of S2308, smooth CICVyA-INTA
    B. abortus Δomp19(pBBR4-gfp) Kanr Ampr, mutant of S2308, smooth This study
    B. abortus Δomp19(pBBR1-omp19) Kanr Cmr, mutant of S2308, smooth CICVyA-INTA
    B. abortus Δomp19 (pBBR1-omp19, pBBR4-gfp) Kanr Cmr Ampr, mutant of S2308, smooth This study
E. coli strains
    E. coli BL21 Competent strain for protein expression LIDI
    E. coli S17 Competent conjugative donor strain LIDI
Plasmid
    GFP pBBR4-gfp Ampr DNA 2.0
a

Kanr, kanamycin resistance; Ampr, ampicillin resistance; Cmr, chloramphenicol resistence.

b

LIDI, Laboratório de Imunologia de Doenças Infecciosas, UFMG, Belo Horizonte, Brazil; CICVyA-INTA, Instituto de Biotecnología, CICVyA-INTA, Buenos Aires, Argentina (Silvio L. Cravero).